Tuesday 7 April 2009

Biotechnology Industry Organization

About BIO

BIO was founded in 1993 and is based in Washington D.C. under the leadership of President and CEO, James C. Greenwood. Joshua Boger, PhD, President & CEO, Vertex Pharmaceuticals Incorporated, is the current Chairman.

Biotechnology Industry Organization

Biotechnology Industry Organization

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.

BIO Mission Statement

Biotechnology researchers expand the boundaries of science to benefit mankind by providing better healthcare, enhanced agriculture, and a cleaner and safer environment.

The mission of the Biotechnology Industry Organization (BIO) is to be the champion of biotechnology and the advocate for its member organizations-both large and small.

BIO Membership

Corporate R&D members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. The majority of our members are small companies- 90 percent have annual revenues of $25 million or less, reflecting the broader biotechnology industry. BIO also represents academic centers, state and regional biotech associations and service providers to the industry, including financial and consulting firms.

  • R&D-Intensive Companies: 68%. Of those:
    · 90% have annual revenues under $25 million
    · 5% have annual revenues between $25 million and $1 billion
    · 5% have annual revenues over $1 billion
  • Nonprofit/Academic: 15%
  • Service Providers: 12%
  • State/International Affiliate Organizations: 5%

BIO International Convention

BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

The BIO International Convention showcases the many ways the biotechnology and life science industries work together to help heal, fuel, and feed the world. In 2009, more than 20,000 people from across the globe are expected to converge in Atlanta, Ga. on May 18-21 to attend the global event for biotechnology.



BIO Announces Policy Panel Keynote Session for 2009 BIO International Convention

BIO Announces Policy Panel Keynote Session for 2009 BIO International Convention

Senator Tom Daschle, Governor Howard Dean, Senator William H. Frist, and Karl Rove to Participate

2009 BIO International Convention

WASHINGTON--(BUSINESS WIRE)--Democratic and Republican party leaders and political operatives will discuss their differing perspectives on the challenges and opportunities associated with the comprehensive reform of the U.S. healthcare system during a keynote panel, titled "The Challenges and Opportunities Surrounding Healthcare Reform," taking place Wednesday, May 20 from 12:00 – 1:45 p.m. at the Georgia World Congress Center during the Keynote Luncheon at the 2009 BIO International Convention.

Moderated by Susan Dentzer of The NewsHour with Jim Lehrer, the panel will include Senator Tom Daschle, Governor Howard Dean, Senator William H. Frist, M.D., and Karl Rove.

"This panel provides an opportunity to discuss and debate the best options and opportunities for the new administration as they move toward their goal of restructuring our nation's health care system," said James C. Greenwood, president and CEO, BIO. "As the Obama Administration and Congress explore how to restructure the delivery of the nation's health care services, it is important that the biotech industry is involved in the debate."

The panel will address the road to a new health care system in the United States, providing a preview to the debates expected to take place in Congress later this year. Panel members bring with them a vast array of experience in government service, from Congress to the Governorship and Chief of Staff to former President George W. Bush.

The BIO International Convention, hosted by the Biotechnology Industry Organization (BIO), will take place May 18-21, 2009, in Atlanta. Each year, the BIO International Convention draws approximately 20,000 industry leaders from 60 countries. This year, the Convention program will feature more than 170 sessions in 22 breakout session tracks. Sessions will address the most pressing issues facing biotech today, including healthcare pricing and access, capital formation and partnering strategies in a tight credit environment, and climate change and biofuels.

In addition, this year's BIO Exhibition will cover will cover an estimated 200,000 net sq. ft. and host more than 2,000 exhibitors.

To register for the BIO International Convention, please visit http://convention.bio.org/

Advanced media registration will be available online through May 8, 2009. To register, please visithttp://convention.bio.org/media/registration.

The BIO International Convention helps to support BIO programs and initiatives. BIO works throughout the year to create a policy environment that enables the industry to continue to fulfill its vision of bettering the world through biotechnology innovation. For more information on the global event for biotechnology, including program and housing information, please visit http://convention.bio.org/.

Upcoming BIO Events

BIO Windhover 2009
April 13-15, 2009
New York, NY

BIO-LES Business Development Basics Course
May 15–17, 2009
Atlanta, GA

BIO-LES Advanced Business Development Course
May 15–17, 2009
Atlanta, GA

BIO Executive Presentation Workshop
May 17, 2009
Atlanta, GA

BIO Human Resources Conference
May 17-19, 2009
Atlanta, GA

2009 BIO International Convention
May 18-21, 2009
Atlanta, GA

BioEquity Europe
June 9-10, 2009
Munich, Germany

World Congress on Industrial Biotechnology & Bioprocessing
July 19-22, 2009
Montreal, Quebec, Canada

About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.


Contacts

Biotechnology Industry Organization (BIO)
Tracy Krughoff, 202-312-9274
http://convention.bio.org